Navigation Links
Researchers engineer pancreatic cell transplants to evade immune response
Date:12/31/2008

In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

At present, cell transplantation therapy is limited because transplant recipients are forced to take powerful immunosuppressant medications that have toxic side effects and raise the risk of infection. This advance in mice, described in the online version of Gene Therapy, could pave the way for routine use of cell transplants as a therapy for type 1 diabetes in humans.

Type 1 diabetes is an incurable autoimmune disease in which the immune system mistakenly destroys the body's own pancreatic beta cells. Beta cells produce insulin, which breaks down sugar, or glucose, for use by the body. Without these cells, too much glucose builds up in the blood. High blood glucose levels damage cells and can eventually lead to complications such as heart disease, kidney disease, blindness, and premature death.

Type 1 diabetes affects up to 2.4 million Americans and can develop at any age, though it typically appears during childhood or adolescence. People with type 1 diabetes must closely monitor their blood glucose levels and take daily insulin injections for life.

A promising alternative to insulin injections is cellular transplantation, in which beta cells are harvested from cadavers and injected into the bloodstream of patients with diabetes; the new cells replace the recipients' destroyed pancreatic beta cells. Although such transplants can control type 1 diabetes, recipients must take immunosuppressant medications in order to prevent rejection of these beta foreign cells. "Ultimately, even with immunosuppressive therapy, most of these individuals end up rejecting the transplanted cells," says the study's principal investigator, Ha
'/>"/>

Contact: Mike Heller
mheller@aecom.yu.edu
718-430-4186
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UC Davis researchers find molecule that targets brain tumors
2. UT Public Health researchers find link to severe Staph infections
3. SUNY Downstate researchers find that memory storage molecule preserves complex memories
4. Researchers make breakthrough in the production of double-walled carbon nanotubes
5. Researchers find chink in the armor of viral tummy bug
6. Biomedical researchers create artificial human bone marrow in a test tube
7. Princeton researchers discover new type of laser
8. UT Southwestern researchers identify gene linked to inherited form of fatal lung disease
9. James Thomson receives 2008 Massry Prize honoring stem cell researchers
10. Researchers push nature beyond its limits to create higher-density biofuels
11. Researchers advance knowledge of little nano-machines in our body

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...A team of scientists from the U.S. Department of E...ard University, and the Indian Institute of Scienc...ules locate the genetic information in DNA that is...sses. The research, published in the December 1, 2...ogy , confirms that many proteins responsible for ...
(Date:12/2/2009)...HIA Cigarette smoking and alcohol consumption bef...ts the patient,s future risk of death, according t...how a similar effect among those who continued the... survivors are counseled to quit smoking; despite ...ontinued to smoke even after their cancer diagnosi...
(Date:12/2/2009)...TTE, Ind. ╤ A Smoky Mountain forest,s woodla... a role in how forest understories recover from lo... Despite heavy logging in portions of the forest ...plants on the secondary forest floor was similar t...rdue assistant professor of forestry and natural r...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Study finds logging effects vary based on a forest's history, climate 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 1Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 13898 5Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 1Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 2Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 3
...ble energy technology is needed if the United Stat...y and motor vehicle fuel from renewable sources by...sts, according to a RAND Corporation study issued ... and Economic Development program, the study provi...expenditures if a requirement was imposed that 25 ...
...ery June for 30 years, Terry McEneaney drove aroun...he heard along three routes. , Park ornithologist...and identify the birds there. Then he,d drive anot...il he had stopped 50 times in 24.5 miles for the N...sh before the birds quit singing, he,d ignore the ...
... Behavioral Ecology Congress , WHEN: August 10...Y. , WHO: Hosted by the International Society for...e welcome to attend the 12th International Behavio...Society for Behavioral Ecology, Aug. 10 -14, 2008,...eatures a wide variety of human and animal behavio...
Other Biology News:Major progress in technology needed for 25 percent renewable energy use to be affordable 2Major progress in technology needed for 25 percent renewable energy use to be affordable 3Bird watchers, space technology come together in Montana State University study 2Bird watchers, space technology come together in Montana State University study 3
(Date:12/2/2009)..., Dec. 2 Reportlinker.com announce...n its catalogue: ,, Neurostimulation - A Globa...er.com/p0164232/Neurostimulation---A-Global-Market...on market stands enthused by the growing base of a...ated diseases such as, Parkinson,s, and Alzheimer,...
(Date:12/2/2009)...if., Dec. 2 Peregrine Ph...d completion of patient enrollment in a dose confi...ients with relapsed glioblastoma multiforme (GBM),...targeted monoclonal antibody linked to a radioisot...or GBM. Cotara specifically targets cells at the ...
(Date:12/2/2009)...USALEM, Israel, December 2 Gamida ...g the preclinical (animal study) safety and,effica...logy from Weill,Cornell Medical College and Gamida...erited anemias such as Cooley,s Anemia. , ...s to expand, ex vivo,populations of stem/progenit...
(Date:12/2/2009)...I, Dec. 2 /PRNewswire-Asia/ -- The world is going ...l and uncertainty is part of many,businesses and i...as been,relatively immune to the economic downturn... During the midst of the difficult times this y...n inaugurated an R&D center in Shanghai, the l...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...aceutical Inc. (Nasdaq: BMRN ) today announced th...of BioMarin, will present a company,update at the ... Phoenix,Arizona on Wednesday, November 12, 2008 a...a live audio webcast of the conference,call via th...//www.BMRN.com .,A replay of the call will be arch...
...maceuticals, Inc. (Nasdaq: PPHM ) today announced... & Renshaw 10th Annual Healthcare Conference on,Tu...ence will be held at,the New York Palace Hotel in ...onference, please visit:, http://www.rodmanandrens...aceuticals, Peregrine Pharmaceuticals, Inc. is a ...
...MONTON, Nov. 5 /PRNewswire-FirstCall/ - BioMS Medi...tment of multiple sclerosis (MS), today,announced ...ent at the,Rodman and Renshaw 10th Annual Healthca...ember 10th at 12:00pm (Eastern Time), WHERE: N...cal Corp. ------------------------- BioMS Medica...
Other Biology Technology:BioMarin to Present at the Credit Suisse Healthcare Conference 2BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference 2
SigmaScreen APS Coated Slides for Microarrays from Sigma-Aldrich
Bromophenol Blue sodium salt from Sigma-Aldrich
DAPI from KPL
LV-2080 Solvent Switching Valve from JASCO
Biology Products: